Increasingly, researchers are suggesting that amyloid plaques and neurofibrillary tangles may be relatively late manifestations in the course of Alzheimer's disease (AD) pathology. Identifying earlier events in the development ...
Jun 28, 2011
0
0
The influenza pandemic that began in Mexico in April 2009 rapidly spread throughout the world and arrived in Japan one month later. Now, a research team led by Toshihisa Ishikawa at the RIKEN Omics Science Center in Yokohama ...
Jul 15, 2011
0
0
Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments, they report today in the journal Nature Medicine.
May 22, 2011
0
0
Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have characterized a protein produced by the soil bacterium Bacillus thuringiensis subsp. israelensis (Bti), which is highly toxic against Anopheles ...
Jun 5, 2013
0
0
Persons with high cholesterol who received counseling regarding a diet that combined cholesterol-lowering foods such as soy protein, nuts and plant sterols over 6 months experienced a greater reduction in their low-density ...
Aug 23, 2011
0
1
Researchers at the Francis Crick Institute and Charité – Universitätsmedizin Berlin have identified 27 protein biomarkers that could be used to predict whether a patient with COVID-19 is likely to become severely ill ...
Jun 2, 2020
0
27
Johnson and Johnson recently announced that it was halting a clinical trial for a new Alzheimer's drug after safety issues emerged. This latest failure adds to the dozens of large, costly clinical trials that have shown no ...
Jun 6, 2018
1
14
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported in Oncogene, tumors treated with the ...
Sep 4, 2023
0
172
Researchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.
Apr 28, 2016
0
21
A new study shows that when an experimental cancer medication is split in half, the molecule becomes safer and more effective.
Nov 11, 2022
0
55
